Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q3 FY22 results · Oct–Dec 2021
Camlin Fine Sciences reported revenue from operations of ₹380.82 crore (up 27.8% from Q3 FY21) and net profit of ₹27.15 crore (up 39.8% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 380.82 | 297.92 | +27.8% | 311.22 | +22.4% |
| Other income | 5.58 | 1.14 | +388.3% | 0.62 | +800.4% |
| Total income | 386.40 | 299.07 | +29.2% | 311.84 | +23.9% |
| Profit before tax | 40.69 | 27.81 | +46.3% | 0.91 | 45x |
| Net profit for the period | 27.15 | 19.42 | +39.8% | (3.88) | Turned profit |
| EPS, basic (₹) | 2.25 | 1.26 | +78.6% | (0.43) | Turned profit |
| Net margin (%) | 7.1 | 6.5 | -1.2 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 200.22 | 163.64 | +22.4% | 138.17 | +44.9% |
| Other income | 7.25 | 1.42 | +412.1% | 1.01 | +618.3% |
| Total income | 207.47 | 165.06 | +25.7% | 139.17 | +49.1% |
| Profit before tax | 17.21 | 4.90 | +251.5% | (10.15) | Turned profit |
| Net profit for the period | 12.38 | 3.36 | +269.0% | (6.99) | Turned profit |
| EPS, basic (₹) | 0.97 | 0.27 | +259.3% | (0.55) | Turned profit |
| Net margin (%) | 6.2 | 2.1 | -5.1 |
Consolidated
- Filed with BSE
- 07 Feb 2022, 17:19 IST
- Board meeting
- 07 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Feb 2022, 17:19 IST
- Board meeting
- 07 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE